Joshua Muia/LinkedIn
Aug 13, 2025, 10:25
Joshua Muia on His HTRS Leadership Role Impact
Joshua Muia, Associate Investigator at Versiti Blood Research Institute, shares a proud post on LinkedIn:
”I am always proud to be part of the Hemostasis and Thrombosis Research Society (HTRS) community and grateful for the opportunities it provides to contribute in various capacities while advancing my professional growth.
HTRS is committed to fostering collaboration among students (all levels), early- and mid-career professionals, and established investigators, strengthening mentorship, and enhancing our collective impact in the field of thrombosis and hemostasis.”
Find mentorship advices from Dr. Muia here.
Stay informed on the waves in Hemostasis and Thrombosis community with Hemostasis Today.
-
Jul 4, 2026, 17:38Michael Stark: Greater Improvements in Cerebral Oxygenation With Restrictive Transfusion Thresholds
-
Jul 4, 2026, 17:27Reza Shojaei: How America Won the Plasma Race
-
Jul 4, 2026, 17:26Akshat Jain: The First CRISPR-Cas9 Gene Therapy Approved for Children as Young as 2 with SCD
-
Jul 4, 2026, 17:25Francesca Palandri: Dynamic, Treatment Response-Driven Risk Assessment in Polycythemia Vera
-
Jul 4, 2026, 17:24Thierry Burnouf: The Fragile Supply of Human Hyperimmune Immunoglobulins
-
Jul 4, 2026, 15:41Emmanuel J. Favaloro: New Research Highlights Benchmarks for Low Molecular Weight Heparin Monitoring
-
Jul 4, 2026, 15:38Roshni Kulkarni: Maternal Mortality In Bleeding Disorders
-
Jul 4, 2026, 15:34Alejandro González Veliz: Does Elevated Lp(a) Always Mean the Same Cardiovascular Risk?
-
Jul 4, 2026, 15:20Bruno Pougault: Heparin Monitoring Remains One of the Most Challenging Areas in Laboratory Hemostasis